.jpeg)
Sarah Tao, PhD
Search & Evaluation Immunoglobulin (Ig) Therapeutic Area and Technologies Lead
CSL Behring
Sarah Tao, PhD, is the Search & Evaluation Immunoglobulin (Ig) Therapeutic Area and Technologies Lead at CSL Behring. In this role, she drives the strategic partnering for external innovations across the discovery and development continuum to enhance therapeutic impact and accessibility. Prior to CSL, Dr. Tao served as Head of Search & Evaluation for Technology Platforms within Global Business Development & Licensing at Sanofi, where she led partnerships for scalable, next-generation technologies and modalities with cross–therapeutic area applicability, including artificial intelligence for drug discovery. Earlier in her career at CooperVision and Draper Laboratory, Dr. Tao led a variety of technology innovation programs, such as regenerative medicine, digital health, and human-machine interfaces. Dr. Tao earned her PhD in Biomedical Engineering from Boston University with a research focus on MEMS-based systems for drug delivery. She is recognized contributor to the field and has received multiple honors, including the Controlled Release Society Grand Prize.
Sessions
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}